| Mylan Pharma GmbH - Influvac, Injektionssuspension | | 00485 | | 27 | | Influvac | | Injektionssuspension | | J07BB02 | | Influenza, gereinigtes Antigen | | 30.07.2014 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: reassortant virus NYMC X-181) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Texas/50/2012 (H3N2)-like: reassortant virus NYMC X-223A) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Massachusetts/2/2012-like: reassortant virus NYMC BX-51B) 15 µg, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, natrii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, residui: ovalbuminum max. 0.1 µg, formaldehydum et cetrimidum et polysorbatum 80 et gentamicinum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Suspension injectable | | | | | | Principe actif | Concentr. |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: Reassortant Virus nymc X-181) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/texas/50/2012 (H3N2)-Like: Reassortant Virus nymc X-223a) | 15 µg | | Haemagglutininum Influenzae b (Virus-Stamm B/massachusetts/2/2012-Like: Reassortant Virus nymc Bx-51B) | 15 µg |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 009 | seringue prête à 0.5 ml | 9.10 | 18.65 | B | LS | Oui | | 010 | 10 1 seringue prête à 0.5 ml | DDP | DDP | B | | Oui |
|
|
